Business Development & Partnering
At MDimune, we are passionate about changing the world by developing innovative therapeutics.
Business Areas
01
Development of cancer
therapeutics using
immune cell-derived
vesicles
- Developing targeted drug delivery to cancer cells using vesicles loaded with cytotoxic agents
in vitro and in vivo analyses/preclinical studies for various anticancer drugs underway.
- Developing autologous cancer therapeutics by administering anticancer drugs loaded in
the vesicles that are derived from leukocytes isolated from cancer patients
- Versatile technology to carry various molecular cargos (siRNAs/miRNAs, proteins/peptides, small molecules, etc.)
02
Development of
therapeutics using stem
cell-derived vesicles
- Developing a platform technology using adult stem cell-derived vesicles exhibiting
anti-inflammatory and regenerative properties to treat various diseases
- Improving synergistic effects by combining regenerative potentials of adult stem cell-derived vesicles with known efficacies of various drugs loaded in the vesicles
- Developing therapeutics to treat incurable diseases such as osteoarthritis, COPD,
neurodegenerative diseases, etc
03
Manufacturing and
supply of BioDrone®
drug delivery system
- Providing vesicles derived from immune cells or stem cells to pharmaceutical companies to
promote the development of novel therapeutics
- Providing customized services by producing vesicles from cell types of interest to
facilitate the R&D efforts of pharmaceutical companies
Partnering
MDimune Inc. is partnering with world-renowned
drug development experts to achieve global success.
-
- Collaboration
-
Building a professional network with
universities, research institutes, and
pharmaceutical companies
-
- Global marketing
-
Seeking marketing partners for
the global application of technology
and licensing
-
- Clinical trial
-
Building a clinical trials network with
major hospitals in Korea